CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-14 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-11-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −500 | $460.34 | $230K | 3,630 |
| 2025-11-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,000 | $461.83 | $924K | 1,630 |
| 2025-11-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −930 | $464.84 | $432K | 700 |
| 2025-11-14 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −570 | $466.05 | $266K | 130 |
| 2025-11-14 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 94,000 | ||
| 2025-11-13 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion 10b5-1 | +11,000 | $135.42 | $1.5M | 47,781 |
| 2025-11-13 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −200 | $456.39 | $91K | 47,581 |
| 2025-11-13 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,063 | $458.16 | $487K | 46,518 |
| 2025-11-13 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,040 | $461.36 | $480K | 45,478 |
| 2025-11-13 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −979 | $463.32 | $454K | 44,499 |
| 2025-11-13 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,979 | $464.19 | $919K | 42,520 |
| 2025-11-13 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −776 | $465.37 | $361K | 41,744 |
| 2025-11-13 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −884 | $466.24 | $412K | 40,860 |
| 2025-11-13 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,992 | $467.37 | $931K | 38,868 |
| 2025-11-13 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,070 | $468.48 | $970K | 36,798 |
| 2025-11-13 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −17 | $469.09 | $8K | 36,781 |
| 2025-11-13 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion · Stock Option 10b5-1 | −11,000 | 11,000 | ||
| 2025-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-11-13 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −761 | $458.48 | $349K | 3,369 |
Page 182 of 214 · 4,273 trades